Sandler A - Search Results

1

Combined cisplatin and gemcitabine for non-small cell lung cancer: influence of scheduling on toxicity and drug delivery.

Abratt RP, Sandler A, Crinò L, Steward WP, Shepherd FA, Green MR, Nguyen B, Peters GJ. Abratt RP, et al. Among authors: sandler a. Semin Oncol. 1998 Aug;25(4 Suppl 9):35-43. Semin Oncol. 1998. PMID: 9728583

2

The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer.

Shepherd FA, Abratt R, Crino L, Green M, Sandler A, Steward W, Iglesias J, Anglin G. Shepherd FA, et al. Among authors: sandler a. Lung Cancer. 2000 Nov;30(2):117-25. doi: 10.1016/s0169-5002(00)00135-5. Lung Cancer. 2000. PMID: 11086205

3

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.

Sandler AB, Nemunaitis J, Denham C, von Pawel J, Cormier Y, Gatzemeier U, Mattson K, Manegold C, Palmer MC, Gregor A, Nguyen B, Niyikiza C, Einhorn LH. Sandler AB, et al. J Clin Oncol. 2000 Jan;18(1):122-30. doi: 10.1200/JCO.2000.18.1.122. J Clin Oncol. 2000. PMID: 10623702 Clinical Trial.

4

The activity of gemcitabine plus cisplatin in randomized trials in untreated patients with advanced non-small cell lung cancer.

Rosell R, Tonato M, Sandler A. Rosell R, et al. Among authors: sandler a. Semin Oncol. 1998 Aug;25(4 Suppl 9):27-34. Semin Oncol. 1998. PMID: 9728582 Review.

5

Gemcitabine and paclitaxel combinations in non-small cell lung cancer.

Dombernowsky P, Giaccone G, Sandler A, Schwartsmann G. Dombernowsky P, et al. Among authors: sandler a. Semin Oncol. 1998 Aug;25(4 Suppl 9):44-50. Semin Oncol. 1998. PMID: 9728584 Review.

6

Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.

Niell HB, Herndon JE 2nd, Miller AA, Watson DM, Sandler AB, Kelly K, Marks RS, Perry MC, Ansari RH, Otterson G, Ellerton J, Vokes EE, Green MR; Cancer and Leukemia Group. Niell HB, et al. Among authors: sandler ab. J Clin Oncol. 2005 Jun 1;23(16):3752-9. doi: 10.1200/JCO.2005.09.071. J Clin Oncol. 2005. PMID: 15923572 Clinical Trial.

7

Ongoing and future trials of biologic therapies in lung cancer.

Bunn PA Jr, Shepherd FA, Sandler A, Le Chevalier T, Belani CP, Kosmidis PA, Scagliotti GV, Giaccone G. Bunn PA Jr, et al. Among authors: sandler a. Lung Cancer. 2003 Aug;41 Suppl 1:S175-86. doi: 10.1016/s0169-5002(03)00161-2. Lung Cancer. 2003. PMID: 12867076 Review.

8

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).

Peters S, Gettinger S, Johnson ML, Jänne PA, Garassino MC, Christoph D, Toh CK, Rizvi NA, Chaft JE, Carcereny Costa E, Patel JD, Chow LQM, Koczywas M, Ho C, Früh M, van den Heuvel M, Rothenstein J, Reck M, Paz-Ares L, Shepherd FA, Kurata T, Li Z, Qiu J, Kowanetz M, Mocci S, Shankar G, Sandler A, Felip E. Peters S, et al. Among authors: sandler a. J Clin Oncol. 2017 Aug 20;35(24):2781-2789. doi: 10.1200/JCO.2016.71.9476. Epub 2017 Jun 13. J Clin Oncol. 2017. PMID: 28609226 Free PMC article. Clinical Trial.

9

Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer.

Sandler AB. Sandler AB. Semin Oncol. 1998 Feb;25(1 Suppl 2):38-41. Semin Oncol. 1998. PMID: 9535210 Review.

10

Chemotherapy for small cell lung cancer.

Sandler AB. Sandler AB. Semin Oncol. 2003 Feb;30(1):9-25. doi: 10.1053/sonc.2003.50012. Semin Oncol. 2003. PMID: 12635086 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

612 results

Search Page

Filters